| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | ATP-dependent activity | DNHD1 ABCF3 DYNC2H1 DHX37 TWNK TOR4A BTAF1 IDE MORC4 ABCA7 IQCA1L IQCA1 DQX1 RALBP1 DNA2 DYNC1H1 SLC27A3 | 3.49e-06 | 614 | 149 | 17 | GO:0140657 |
| GeneOntologyMolecularFunction | ATP hydrolysis activity | ABCF3 DYNC2H1 DHX37 TWNK TOR4A BTAF1 IDE MORC4 ABCA7 IQCA1L IQCA1 DQX1 DNA2 DYNC1H1 | 5.77e-06 | 441 | 149 | 14 | GO:0016887 |
| GeneOntologyMolecularFunction | dynein light intermediate chain binding | 5.30e-05 | 28 | 149 | 4 | GO:0051959 | |
| GeneOntologyMolecularFunction | peptide lactyltransferase (CoA-dependent) activity | 5.53e-05 | 2 | 149 | 2 | GO:0120300 | |
| GeneOntologyMolecularFunction | histone H3K27 acetyltransferase activity | 5.53e-05 | 2 | 149 | 2 | GO:0044017 | |
| GeneOntologyMolecularFunction | histone H3K18 acetyltransferase activity | 1.65e-04 | 3 | 149 | 2 | GO:0043993 | |
| GeneOntologyMolecularFunction | ribonucleoside triphosphate phosphatase activity | ABCF3 DYNC2H1 DHX37 LRRK2 TWNK TOR4A BTAF1 IDE MORC4 ABCA7 IQCA1L IQCA1 DQX1 SEPTIN1 DNA2 DYNC1H1 | 2.27e-04 | 775 | 149 | 16 | GO:0017111 |
| GeneOntologyMolecularFunction | minus-end-directed microtubule motor activity | 3.06e-04 | 18 | 149 | 3 | GO:0008569 | |
| GeneOntologyMolecularFunction | protein serine/threonine kinase activity | CDK18 STK36 PDK1 LRRK2 SRPK1 SBK1 TGFBR1 UHMK1 AKT1 AKT2 STKLD1 | 5.32e-04 | 446 | 149 | 11 | GO:0004674 |
| GeneOntologyMolecularFunction | pyrophosphatase activity | ABCF3 DYNC2H1 DHX37 LRRK2 TWNK TOR4A BTAF1 IDE MORC4 ABCA7 IQCA1L IQCA1 DQX1 SEPTIN1 DNA2 DYNC1H1 | 5.43e-04 | 839 | 149 | 16 | GO:0016462 |
| GeneOntologyMolecularFunction | hydrolase activity, acting on acid anhydrides | ABCF3 DYNC2H1 DHX37 LRRK2 TWNK TOR4A BTAF1 IDE MORC4 ABCA7 IQCA1L IQCA1 DQX1 SEPTIN1 DNA2 DYNC1H1 | 5.50e-04 | 840 | 149 | 16 | GO:0016817 |
| GeneOntologyMolecularFunction | hydrolase activity, acting on acid anhydrides, in phosphorus-containing anhydrides | ABCF3 DYNC2H1 DHX37 LRRK2 TWNK TOR4A BTAF1 IDE MORC4 ABCA7 IQCA1L IQCA1 DQX1 SEPTIN1 DNA2 DYNC1H1 | 5.50e-04 | 840 | 149 | 16 | GO:0016818 |
| GeneOntologyMolecularFunction | protein serine/threonine kinase binding | 7.35e-04 | 24 | 149 | 3 | GO:0120283 | |
| GeneOntologyMolecularFunction | clathrin binding | 1.26e-03 | 63 | 149 | 4 | GO:0030276 | |
| HumanPheno | Broad eyebrow | 1.19e-05 | 29 | 55 | 5 | HP:0011229 | |
| HumanPheno | Absent earlobe | 5.19e-05 | 20 | 55 | 4 | HP:0000387 | |
| HumanPheno | Reduced social responsiveness | 7.04e-05 | 170 | 55 | 9 | HP:0012760 | |
| HumanPheno | Gait disturbance | CEP104 EMC1 COPB1 SZT2 DYNC2H1 MYOD1 VPS13C LRRK2 INTS1 CARS1 WDR81 TWNK NSUN2 INTS8 CREBBP POLR3A TCEAL1 SYNGAP1 CYP2R1 SACS FDXR CLTC AKT1 HERC1 DNA2 SLC9A6 EP300 DYNC1H1 | 9.83e-05 | 1356 | 55 | 28 | HP:0001288 |
| HumanPheno | Plantar crease between first and second toes | 1.14e-04 | 2 | 55 | 2 | HP:0008107 | |
| HumanPheno | Aortic isthmus hypoplasia | 1.14e-04 | 2 | 55 | 2 | HP:0034227 | |
| HumanPheno | High axial triradius | 1.14e-04 | 2 | 55 | 2 | HP:0001042 | |
| Domain | ARM-type_fold | DOCK1 TNPO1 DOCK2 CEP104 STK36 COPB1 HGH1 LRRK2 INTS1 PSMD2 BTAF1 HEATR1 AP1B1 AP2B1 CLTC WDFY3 STKLD1 UNC79 TANGO6 | 3.63e-11 | 339 | 151 | 19 | IPR016024 |
| Domain | ARM-like | TNPO1 DOCK2 CEP104 STK36 COPB1 HGH1 LRRK2 PSMD2 BTAF1 HEATR1 AP1B1 AP2B1 WDFY3 STKLD1 TANGO6 | 5.32e-09 | 270 | 151 | 15 | IPR011989 |
| Domain | - | TNPO1 CEP104 STK36 COPB1 HGH1 LRRK2 PSMD2 BTAF1 HEATR1 AP1B1 AP2B1 WDFY3 TANGO6 | 3.14e-08 | 222 | 151 | 13 | 1.25.10.10 |
| Domain | HEAT | 4.18e-05 | 48 | 151 | 5 | PF02985 | |
| Domain | Nuc_rcpt_coact_CREBbp | 6.49e-05 | 2 | 151 | 2 | IPR014744 | |
| Domain | ZnF_TAZ | 6.49e-05 | 2 | 151 | 2 | SM00551 | |
| Domain | - | 6.49e-05 | 2 | 151 | 2 | 1.20.1020.10 | |
| Domain | RING_CBP-p300 | 6.49e-05 | 2 | 151 | 2 | IPR010303 | |
| Domain | - | 6.49e-05 | 2 | 151 | 2 | 1.10.1630.10 | |
| Domain | Creb_binding | 6.49e-05 | 2 | 151 | 2 | PF09030 | |
| Domain | zf-TAZ | 6.49e-05 | 2 | 151 | 2 | PF02135 | |
| Domain | ZF_TAZ | 6.49e-05 | 2 | 151 | 2 | PS50134 | |
| Domain | Clathrin_b-adaptin_app_Ig-like | 6.49e-05 | 2 | 151 | 2 | IPR013037 | |
| Domain | KAT11 | 6.49e-05 | 2 | 151 | 2 | SM01250 | |
| Domain | Znf_TAZ | 6.49e-05 | 2 | 151 | 2 | IPR000197 | |
| Domain | KIX | 6.49e-05 | 2 | 151 | 2 | PF02172 | |
| Domain | HAT_KAT11 | 6.49e-05 | 2 | 151 | 2 | PF08214 | |
| Domain | KIX | 6.49e-05 | 2 | 151 | 2 | PS50952 | |
| Domain | CBP_P300_HAT | 6.49e-05 | 2 | 151 | 2 | IPR031162 | |
| Domain | DUF902 | 6.49e-05 | 2 | 151 | 2 | PF06001 | |
| Domain | - | 6.49e-05 | 2 | 151 | 2 | 2.60.40.1150 | |
| Domain | - | 6.49e-05 | 2 | 151 | 2 | 1.10.246.20 | |
| Domain | Histone_AcTrfase_Rtt109/CBP | 6.49e-05 | 2 | 151 | 2 | IPR013178 | |
| Domain | KIX_dom | 6.49e-05 | 2 | 151 | 2 | IPR003101 | |
| Domain | CBP_P300_HAT | 6.49e-05 | 2 | 151 | 2 | PS51727 | |
| Domain | HEAT | 1.05e-04 | 58 | 151 | 5 | IPR000357 | |
| Domain | Dynein_HC_stalk | 1.77e-04 | 14 | 151 | 3 | IPR024743 | |
| Domain | Dynein_heavy_dom-2 | 1.77e-04 | 14 | 151 | 3 | IPR013602 | |
| Domain | DHC_N2 | 1.77e-04 | 14 | 151 | 3 | PF08393 | |
| Domain | MT | 1.77e-04 | 14 | 151 | 3 | PF12777 | |
| Domain | AP_complex_bsu_1_2_4 | 1.94e-04 | 3 | 151 | 2 | IPR016342 | |
| Domain | B2-adapt-app_C | 1.94e-04 | 3 | 151 | 2 | PF09066 | |
| Domain | DHC_fam | 2.19e-04 | 15 | 151 | 3 | IPR026983 | |
| Domain | Clathrin/coatomer_adapt-like_N | 2.19e-04 | 15 | 151 | 3 | IPR002553 | |
| Domain | Dynein_heavy | 2.19e-04 | 15 | 151 | 3 | PF03028 | |
| Domain | Adaptin_N | 2.19e-04 | 15 | 151 | 3 | PF01602 | |
| Domain | Dynein_heavy_dom | 2.19e-04 | 15 | 151 | 3 | IPR004273 | |
| Domain | HEAT_REPEAT | 2.56e-04 | 70 | 151 | 5 | PS50077 | |
| Domain | B2-adapt-app_C | 3.85e-04 | 4 | 151 | 2 | SM01020 | |
| Domain | B-adaptin_app_sub_C | 3.85e-04 | 4 | 151 | 2 | IPR015151 | |
| Domain | - | 5.34e-04 | 20 | 151 | 3 | 3.30.565.10 | |
| Domain | HATPase_C | 6.19e-04 | 21 | 151 | 3 | IPR003594 | |
| Domain | AP_beta | 6.39e-04 | 5 | 151 | 2 | IPR026739 | |
| Domain | DOCK_N | 6.39e-04 | 5 | 151 | 2 | PF16172 | |
| Domain | DOCK_N | 6.39e-04 | 5 | 151 | 2 | IPR032376 | |
| Domain | Nuc_rcpt_coact | 9.53e-04 | 6 | 151 | 2 | IPR009110 | |
| Domain | Beta2_adaptin/TBP_C_dom | 9.53e-04 | 6 | 151 | 2 | IPR012295 | |
| Domain | - | 9.53e-04 | 6 | 151 | 2 | 3.30.310.10 | |
| Domain | - | DNHD1 ABCF3 GTPBP6 DYNC2H1 DHX37 LRRK2 TWNK TOR4A BTAF1 ABCA7 IQCA1 DQX1 SEPTIN1 DNA2 DYNC1H1 | 1.07e-03 | 746 | 151 | 15 | 3.40.50.300 |
| Domain | Pkinase | 1.09e-03 | 381 | 151 | 10 | PF00069 | |
| Domain | Munc13_1 | 1.33e-03 | 7 | 151 | 2 | IPR014770 | |
| Domain | MHD1 | 1.33e-03 | 7 | 151 | 2 | PS51258 | |
| Domain | DUF1041 | 1.33e-03 | 7 | 151 | 2 | PF06292 | |
| Domain | CAPS_dom | 1.33e-03 | 7 | 151 | 2 | IPR010439 | |
| Domain | P-loop_NTPase | DNHD1 ABCF3 GTPBP6 DYNC2H1 DHX37 LRRK2 TWNK TOR4A BTAF1 ABCA7 MYO15B IQCA1 DQX1 SEPTIN1 DNA2 DYNC1H1 | 1.41e-03 | 848 | 151 | 16 | IPR027417 |
| Domain | DHC_N1 | 1.76e-03 | 8 | 151 | 2 | PF08385 | |
| Domain | Coatomer/calthrin_app_sub_C | 1.76e-03 | 8 | 151 | 2 | IPR009028 | |
| Domain | Dynein_heavy_dom-1 | 1.76e-03 | 8 | 151 | 2 | IPR013594 | |
| Domain | Alpha_adaptinC2 | 2.25e-03 | 9 | 151 | 2 | PF02883 | |
| Domain | BEACH | 2.25e-03 | 9 | 151 | 2 | PS50197 | |
| Domain | Beach | 2.25e-03 | 9 | 151 | 2 | PF02138 | |
| Domain | - | 2.25e-03 | 9 | 151 | 2 | 1.10.1540.10 | |
| Domain | Beach | 2.25e-03 | 9 | 151 | 2 | SM01026 | |
| Domain | Clathrin_a/b/g-adaptin_app_Ig | 2.25e-03 | 9 | 151 | 2 | IPR008152 | |
| Domain | BEACH_dom | 2.25e-03 | 9 | 151 | 2 | IPR000409 | |
| Domain | Alpha_adaptinC2 | 2.25e-03 | 9 | 151 | 2 | SM00809 | |
| Domain | Ser/Thr_kinase_AS | 2.52e-03 | 357 | 151 | 9 | IPR008271 | |
| Domain | S_TKc | 2.62e-03 | 359 | 151 | 9 | SM00220 | |
| Domain | PROTEIN_KINASE_ST | 2.77e-03 | 362 | 151 | 9 | PS00108 | |
| Domain | Leu-rich_rpt_4 | 2.80e-03 | 10 | 151 | 2 | IPR025875 | |
| Domain | LRR_5 | 2.80e-03 | 10 | 151 | 2 | PF13306 | |
| Domain | LRR_5 | 2.80e-03 | 10 | 151 | 2 | IPR026906 | |
| Domain | LRR_4 | 2.80e-03 | 10 | 151 | 2 | PF12799 | |
| Domain | DHR-1_domain | 3.40e-03 | 11 | 151 | 2 | IPR027007 | |
| Domain | DHR_2 | 3.40e-03 | 11 | 151 | 2 | PS51651 | |
| Domain | DHR_1 | 3.40e-03 | 11 | 151 | 2 | PS51650 | |
| Domain | DHR-2 | 3.40e-03 | 11 | 151 | 2 | PF06920 | |
| Domain | DOCK | 3.40e-03 | 11 | 151 | 2 | IPR026791 | |
| Domain | DOCK_C | 3.40e-03 | 11 | 151 | 2 | IPR010703 | |
| Domain | DOCK-C2 | 3.40e-03 | 11 | 151 | 2 | PF14429 | |
| Domain | DHR-2 | 3.40e-03 | 11 | 151 | 2 | IPR027357 | |
| Domain | Coatomer/clathrin_app_Ig-like | 4.06e-03 | 12 | 151 | 2 | IPR013041 | |
| Domain | PROTEIN_KINASE_ATP | 4.20e-03 | 459 | 151 | 10 | PS00107 | |
| Domain | Kinase-like_dom | CDK18 STK36 LRRK2 WDR81 SRPK1 SBK1 TGFBR1 UHMK1 AKT1 AKT2 STKLD1 | 4.63e-03 | 542 | 151 | 11 | IPR011009 |
| Domain | Dynein_heavy_chain_D4_dom | 5.54e-03 | 14 | 151 | 2 | IPR024317 | |
| Domain | ATPase_dyneun-rel_AAA | 5.54e-03 | 14 | 151 | 2 | IPR011704 | |
| Domain | AAA_8 | 5.54e-03 | 14 | 151 | 2 | PF12780 | |
| Domain | AAA_5 | 5.54e-03 | 14 | 151 | 2 | PF07728 | |
| Domain | AAA | 6.33e-03 | 144 | 151 | 5 | SM00382 | |
| Domain | AAA+_ATPase | 6.33e-03 | 144 | 151 | 5 | IPR003593 | |
| Domain | Prot_kinase_dom | 6.49e-03 | 489 | 151 | 10 | IPR000719 | |
| Domain | PROTEIN_KINASE_DOM | 6.86e-03 | 493 | 151 | 10 | PS50011 | |
| Pathway | REACTOME_RUNX2_REGULATES_GENES_INVOLVED_IN_CELL_MIGRATION | 1.95e-05 | 8 | 101 | 3 | M27806 | |
| Pathway | REACTOME_ESTROGEN_DEPENDENT_NUCLEAR_EVENTS_DOWNSTREAM_OF_ESR_MEMBRANE_SIGNALING | 2.91e-05 | 9 | 101 | 3 | MM15666 | |
| Pathway | WP_GROWTH_FACTORS_AND_HORMONES_IN_BETA_CELL_PROLIFERATION | 3.29e-05 | 26 | 101 | 4 | M48092 | |
| Pathway | REACTOME_REGULATION_OF_BETA_CELL_DEVELOPMENT | 2.25e-04 | 42 | 101 | 4 | M17541 | |
| Pathway | BIOCARTA_TGFB_PATHWAY | 2.26e-04 | 17 | 101 | 3 | MM1509 | |
| Pathway | REACTOME_KEAP1_NFE2L2_PATHWAY | 2.75e-04 | 125 | 101 | 6 | M45021 | |
| Pathway | BIOCARTA_TGFB_PATHWAY | 3.18e-04 | 19 | 101 | 3 | M18933 | |
| Pathway | REACTOME_NFE2L2_REGULATING_ANTI_OXIDANT_DETOXIFICATION_ENZYMES | 3.18e-04 | 19 | 101 | 3 | M46442 | |
| Pathway | REACTOME_FOXO_MEDIATED_TRANSCRIPTION | 4.98e-04 | 22 | 101 | 3 | MM15656 | |
| Pathway | BIOCARTA_NTHI_PATHWAY | 4.98e-04 | 22 | 101 | 3 | MM1443 | |
| Pathway | REACTOME_NFE2L2_REGULATING_INFLAMMATION_ASSOCIATED_GENES | 5.01e-04 | 5 | 101 | 2 | M48020 | |
| Pathway | REACTOME_NFE2L2_REGULATING_ER_STRESS_ASSOCIATED_GENES | 5.01e-04 | 5 | 101 | 2 | M48023 | |
| Pathway | BIOCARTA_PELP1_PATHWAY | 5.01e-04 | 5 | 101 | 2 | MM1575 | |
| Pathway | KEGG_MEDICUS_VARIANT_LOSS_OF_NKX3_1_TO_PI3K_SIGNALING_PATHWAY | 5.01e-04 | 5 | 101 | 2 | M48999 | |
| Pathway | REACTOME_LRR_FLII_INTERACTING_PROTEIN_1_LRRFIP1_ACTIVATES_TYPE_I_IFN_PRODUCTION | 5.01e-04 | 5 | 101 | 2 | M27228 | |
| Pathway | BIOCARTA_NTHI_PATHWAY | 5.70e-04 | 23 | 101 | 3 | M2821 | |
| Pathway | WP_TGFBETA_RECEPTOR_SIGNALING | 6.40e-04 | 55 | 101 | 4 | M39351 | |
| Pathway | REACTOME_ESTROGEN_DEPENDENT_NUCLEAR_EVENTS_DOWNSTREAM_OF_ESR_MEMBRANE_SIGNALING | 6.48e-04 | 24 | 101 | 3 | M27952 | |
| Pathway | BIOCARTA_HDAC_PATHWAY | 7.32e-04 | 25 | 101 | 3 | M1547 | |
| Pathway | BIOCARTA_PELP1_PATHWAY | 7.48e-04 | 6 | 101 | 2 | M22062 | |
| Pathway | KEGG_MEDICUS_REFERENCE_MAGI_PTEN_SIGNALING_PATHWAY | 7.48e-04 | 6 | 101 | 2 | M47523 | |
| Pathway | WP_HEPATITIS_B_INFECTION | 7.51e-04 | 151 | 101 | 6 | M39801 | |
| Pathway | BIOCARTA_HDAC_PATHWAY | 8.23e-04 | 26 | 101 | 3 | MM1371 | |
| Pathway | PID_HDAC_CLASSIII_PATHWAY | 8.23e-04 | 26 | 101 | 3 | M32 | |
| Pathway | PID_P53_REGULATION_PATHWAY | 8.35e-04 | 59 | 101 | 4 | M261 | |
| Pathway | WP_TGFBETA_RECEPTOR_SIGNALING_IN_SKELETAL_DYSPLASIAS | 8.35e-04 | 59 | 101 | 4 | M39886 | |
| Pathway | REACTOME_THE_ROLE_OF_NEF_IN_HIV_1_REPLICATION_AND_DISEASE_PATHOGENESIS | 1.03e-03 | 28 | 101 | 3 | M11362 | |
| Pathway | KEGG_MEDICUS_VARIANT_MUTATION_ACTIVATED_PI3K_TO_PI3K_SIGNALING_PATHWAY | 1.04e-03 | 7 | 101 | 2 | M47407 | |
| Pathway | KEGG_MEDICUS_REFERENCE_ACH_CHRN_PI3K_SIGNALING_PATHWAY | 1.04e-03 | 7 | 101 | 2 | M47790 | |
| Pathway | BIOCARTA_PPARG_PATHWAY | 1.04e-03 | 7 | 101 | 2 | MM1573 | |
| Pathway | WP_LIPID_METABOLISM_PATHWAY | 1.14e-03 | 29 | 101 | 3 | M39762 | |
| Pathway | REACTOME_REGULATION_OF_TP53_ACTIVITY_THROUGH_ACETYLATION | 1.14e-03 | 29 | 101 | 3 | MM15340 | |
| Pathway | PID_RETINOIC_ACID_PATHWAY | 1.26e-03 | 30 | 101 | 3 | M207 | |
| Pathway | REACTOME_REGULATION_OF_TP53_ACTIVITY_THROUGH_ACETYLATION | 1.26e-03 | 30 | 101 | 3 | M27637 | |
| Pathway | REACTOME_FOXO_MEDIATED_TRANSCRIPTION | 1.27e-03 | 66 | 101 | 4 | M27938 | |
| Pathway | BIOCARTA_PPARG_PATHWAY | 1.38e-03 | 8 | 101 | 2 | M22058 | |
| Pathway | KEGG_MEDICUS_VARIANT_AMPLIFIED_PDGFR_TO_PI3K_SIGNALING_PATHWAY | 1.38e-03 | 8 | 101 | 2 | M47399 | |
| Pathway | REACTOME_NFE2L2_REGULATING_MDR_ASSOCIATED_ENZYMES | 1.38e-03 | 8 | 101 | 2 | M48022 | |
| Pathway | KEGG_MEDICUS_VARIANT_AMPLIFIED_EGFR_TO_PI3K_SIGNALING_PATHWAY | 1.38e-03 | 8 | 101 | 2 | M47394 | |
| Pathway | KEGG_MEDICUS_VARIANT_MUTATION_ACTIVATED_EGFR_TO_PI3K_SIGNALING_PATHWAY | 1.38e-03 | 8 | 101 | 2 | M47395 | |
| Pathway | REACTOME_REGULATION_OF_NFE2L2_GENE_EXPRESSION | 1.38e-03 | 8 | 101 | 2 | M48024 | |
| Pathway | KEGG_MEDICUS_VARIANT_MUTATION_ACTIVATED_KIT_TO_PI3K_SIGNALING_PATHWAY | 1.38e-03 | 8 | 101 | 2 | M47404 | |
| Pathway | KEGG_MEDICUS_VARIANT_EML4_ALK_FUSION_KINASE_TO_PI3K_SIGNALING_PATHWAY | 1.38e-03 | 8 | 101 | 2 | M47405 | |
| Pathway | KEGG_MEDICUS_REFERENCE_P4_PR_PI3K_SIGNALING_PATHWAY | 1.38e-03 | 8 | 101 | 2 | M47803 | |
| Pathway | KEGG_MEDICUS_VARIANT_MUTATION_ACTIVATED_RET_TO_PI3K_SIGNALING_PATHWAY | 1.38e-03 | 8 | 101 | 2 | M47715 | |
| Pathway | KEGG_MEDICUS_VARIANT_TGFA_OVEREXPRESSION_TO_PI3K_SIGNALING_PATHWAY | 1.38e-03 | 8 | 101 | 2 | M47482 | |
| Pathway | KEGG_MEDICUS_VARIANT_EGF_OVEREXPRESSION_TO_PI3K_SIGNALING_PATHWAY | 1.38e-03 | 8 | 101 | 2 | M47498 | |
| Pathway | REACTOME_NFE2L2_REGULATES_PENTOSE_PHOSPHATE_PATHWAY_GENES | 1.38e-03 | 8 | 101 | 2 | M46443 | |
| Pathway | WP_UROTENSINIIMEDIATED_SIGNALING | 1.50e-03 | 69 | 101 | 4 | M48052 | |
| Pathway | WP_INITIATION_OF_TRANSCRIPTION_AND_TRANSLATION_ELONGATION_AT_THE_HIV1_LTR | 1.52e-03 | 32 | 101 | 3 | M39521 | |
| Pathway | KEGG_RENAL_CELL_CARCINOMA | 1.58e-03 | 70 | 101 | 4 | M13266 | |
| Pathway | KEGG_PANCREATIC_CANCER | 1.58e-03 | 70 | 101 | 4 | M9726 | |
| Pathway | REACTOME_VIRAL_INFECTION_PATHWAYS | DOCK2 UBE2L6 MED8 PSMD2 SRPK1 CREBBP NUP205 AP1B1 AP2B1 VPS33B CLTC AKT1 AKT2 EP300 DYNC1H1 | 1.59e-03 | 888 | 101 | 15 | M48034 |
| Pathway | REACTOME_SIGNALING_BY_WNT | 1.64e-03 | 239 | 101 | 7 | MM14756 | |
| Pathway | WP_NONSMALL_CELL_LUNG_CANCER | 1.76e-03 | 72 | 101 | 4 | M39738 | |
| Pathway | WP_FRAGILE_X_SYNDROME | 1.76e-03 | 121 | 101 | 5 | M39804 | |
| Pathway | KEGG_MEDICUS_VARIANT_AMPLIFIED_FGFR_TO_PI3K_SIGNALING_PATHWAY | 1.77e-03 | 9 | 101 | 2 | M47397 | |
| Pathway | KEGG_MEDICUS_REFERENCE_EGF_EGFR_PI3K_SIGNALING_PATHWAY | 1.77e-03 | 9 | 101 | 2 | M47392 | |
| Pathway | KEGG_MEDICUS_VARIANT_MUTATION_ACTIVATED_KRAS_NRAS_TO_PI3K_SIGNALING_PATHWAY | 1.77e-03 | 9 | 101 | 2 | M47391 | |
| Pathway | KEGG_MEDICUS_VARIANT_MUTATION_ACTIVATED_MET_TO_PI3K_SIGNALING_PATHWAY | 1.77e-03 | 9 | 101 | 2 | M47402 | |
| Pathway | KEGG_MEDICUS_REFERENCE_MEMBRANE_INITIATED_PROGESTERONE_SIGNALING_PATHWAY | 1.77e-03 | 9 | 101 | 2 | M47802 | |
| Pathway | KEGG_MEDICUS_VARIANT_AMPLIFIED_MET_TO_PI3K_SIGNALING_PATHWAY | 1.77e-03 | 9 | 101 | 2 | M47490 | |
| Pathway | KEGG_MEDICUS_REFERENCE_TGFA_EGFR_PI3K_SIGNALING_PATHWAY | 1.77e-03 | 9 | 101 | 2 | M47481 | |
| Pathway | KEGG_MEDICUS_REFERENCE_TLR3_IRF3_SIGNALING_PATHWAY | 1.77e-03 | 9 | 101 | 2 | M47451 | |
| Pathway | KEGG_MEDICUS_REFERENCE_ICOSLG_ICOS_PI3K_SIGNALING_PATHWAY | 1.77e-03 | 9 | 101 | 2 | M47972 | |
| Pathway | REACTOME_RNA_POLYMERASE_III_TRANSCRIPTION | 1.82e-03 | 34 | 101 | 3 | MM15435 | |
| Pubmed | A dual-activity topoisomerase complex regulates mRNA translation and turnover. | STK36 CRYBG2 ACACA GTPBP6 SZT2 TMEM8B INTS1 APEH TWNK TOR4A BTAF1 SMG5 ITGA5 ABCA7 EHBP1L1 CELSR2 NFATC1 A4GALT AKT1 AKT2 WDFY3 HERC1 EP300 DYNC1H1 | 1.32e-10 | 1105 | 154 | 24 | 35748872 |
| Pubmed | TNPO1 ACACA COPB1 DHX37 INTS1 PSMD2 SRPK1 HEATR1 URB2 NSUN2 NUP205 GTF3C1 AP1B1 AP2B1 CLTC DYNC1H1 SON | 5.83e-09 | 653 | 154 | 17 | 22586326 | |
| Pubmed | 2.55e-08 | 8 | 154 | 4 | 17964260 | ||
| Pubmed | Mitochondrial Akt Regulation of Hypoxic Tumor Reprogramming. | 8.51e-08 | 3 | 154 | 3 | 27505672 | |
| Pubmed | TNPO1 EMC1 ACACA COPB1 SZT2 DYNC2H1 NCAPH2 HEATR1 IGBP1 TRAFD1 HOOK1 NFATC1 PANK4 DNA2 SON | 9.25e-08 | 606 | 154 | 15 | 36538041 | |
| Pubmed | LMBR1L regulates lymphopoiesis through Wnt/β-catenin signaling. | TNPO1 EMC1 COPB1 HGH1 DYNC2H1 PSMD2 BTAF1 HEATR1 URB2 NSUN2 INTS8 NUP205 TRAFD1 HOOK1 AP1B1 CLTC DYNC1H1 SLC27A3 | 2.18e-07 | 942 | 154 | 18 | 31073040 |
| Pubmed | TNPO1 EMC1 ABCF3 ACACA COPB1 HGH1 PSMD2 SRPK1 BTAF1 IGBP1 UTS2 AP1B1 AP2B1 PANK4 EP300 | 2.41e-07 | 653 | 154 | 15 | 33742100 | |
| Pubmed | GTPBP6 COPB1 APEH PSMD2 NCAPH2 SMG5 NSUN2 INTS8 CREBBP SYNGAP1 AP2B1 SACS ARHGEF10 RALBP1 CLTC CERCAM WDFY3 UROD CADPS2 EP300 DYNC1H1 | 2.67e-07 | 1285 | 154 | 21 | 35914814 | |
| Pubmed | 3.39e-07 | 4 | 154 | 3 | 9001254 | ||
| Pubmed | Differential roles of p300 and PCAF acetyltransferases in muscle differentiation. | 3.39e-07 | 4 | 154 | 3 | 9659901 | |
| Pubmed | Interaction between acetylated MyoD and the bromodomain of CBP and/or p300. | 3.39e-07 | 4 | 154 | 3 | 11463815 | |
| Pubmed | 3.39e-07 | 4 | 154 | 3 | 10944526 | ||
| Pubmed | 3.39e-07 | 4 | 154 | 3 | 15380363 | ||
| Pubmed | 3.39e-07 | 4 | 154 | 3 | 27166089 | ||
| Pubmed | 3.39e-07 | 4 | 154 | 3 | 27105349 | ||
| Pubmed | 3.39e-07 | 4 | 154 | 3 | 17111365 | ||
| Pubmed | COPB1 INTS1 PSMD2 BTAF1 PCGF6 GTF3C1 NFATC1 CLTC SPINDOC DYNC1H1 | 4.14e-07 | 272 | 154 | 10 | 31010829 | |
| Pubmed | Proteomic profiling of VCP substrates links VCP to K6-linked ubiquitylation and c-Myc function. | ABCF3 ACACA COPB1 DHX37 PSMD2 SRPK1 TOR4A HEATR1 URB2 NSUN2 CREBBP POLR3A NUP205 PCGF6 GTF3C1 AP2B1 VPS33B CLTC WDFY3 DYNC1H1 SON | 6.17e-07 | 1353 | 154 | 21 | 29467282 |
| Pubmed | Human p300 protein is a coactivator for the transcription factor MyoD. | 8.46e-07 | 5 | 154 | 3 | 8621548 | |
| Pubmed | DYNC2H1 MED8 IDE URB2 ITGA5 MORC4 CREBBP EXD3 EHBP1L1 AP1B1 UBP1 CDK5RAP2 WDFY3 EP300 | 1.06e-06 | 638 | 154 | 14 | 31182584 | |
| Pubmed | Proteomic analyses reveal distinct chromatin-associated and soluble transcription factor complexes. | UBR2 ABCF3 TWNK BTAF1 SMG5 HEATR1 CREBBP NUP205 PCGF6 GTF3C1 NFATC1 UBP1 PANK4 ZBTB40 EP300 DYNC1H1 | 1.45e-06 | 857 | 154 | 16 | 25609649 |
| Pubmed | UHRF1 inhibits MDR1 gene transcription and sensitizes breast cancer cells to anticancer drugs. | 1.69e-06 | 6 | 154 | 3 | 20037778 | |
| Pubmed | 1.69e-06 | 6 | 154 | 3 | 12788643 | ||
| Pubmed | Direct interaction between hnRNP-M and CDC5L/PLRG1 proteins affects alternative splice site choice. | DOCK1 TNPO1 DOCK2 ABCF3 COPB1 INTS1 PSMD2 BTAF1 INTS8 MYO15B AP1B1 VPS33B DYNC1H1 | 2.15e-06 | 582 | 154 | 13 | 20467437 |
| Pubmed | TNPO1 CDK18 EMC1 DYNC2H1 PDK1 APEH TWNK SRPK1 HEATR1 TRAPPC8 PCGF6 SACS ARHGEF10 CLMN CLTC PANK4 ASCC2 CDK5RAP2 AKT2 MLLT11 DNA2 | 2.75e-06 | 1487 | 154 | 21 | 33957083 | |
| Pubmed | Genome-wide CRISPR screen identifies HNRNPL as a prostate cancer dependency regulating RNA splicing. | DOCK1 UBR2 INTU SGSM1 ACACA GTPBP6 TMEM8B VPS13C TMPRSS6 BTAF1 IDE CCDC57 INTS8 CREBBP SBK1 EXD3 GTF3C1 NFATC1 CLMN PANK4 EP300 | 2.81e-06 | 1489 | 154 | 21 | 28611215 |
| Pubmed | 2.94e-06 | 7 | 154 | 3 | 23811558 | ||
| Pubmed | 2.94e-06 | 7 | 154 | 3 | 21697490 | ||
| Pubmed | 2.94e-06 | 7 | 154 | 3 | 14517256 | ||
| Pubmed | C9orf72 protein quality control by UBR5-mediated heterotypic ubiquitin chains. | EMC1 ACACA COPB1 DHX37 INTS1 PSMD2 BTAF1 MORC4 NSUN2 POLR3A NUP205 IGBP1 TRAFD1 GTF3C1 CLTC PANK4 QPCT DNA2 DYNC1H1 | 3.25e-06 | 1257 | 154 | 19 | 37317656 |
| Pubmed | KAP1 facilitates reinstatement of heterochromatin after DNA replication. | EMC1 ACACA COPB1 DHX37 HEATR1 URB2 POLR3A NUP205 GTF3C1 VPS33B FDXR CLTC DYNC1H1 SON | 3.32e-06 | 704 | 154 | 14 | 29955894 |
| Pubmed | A BioID-Derived Proximity Interactome for SARS-CoV-2 Proteins. | EMC1 VPS13C WDR81 BTAF1 URB2 TRAPPC8 INTS8 EHBP1L1 AP1B1 ARHGEF10 FDXR ITPRIP HERC1 UROD | 4.22e-06 | 719 | 154 | 14 | 35337019 |
| Pubmed | DOCK2 LRRC8C ABCF3 COPB1 INTS1 PSMD2 NCAPH2 HEATR1 POLR3A NUP205 EHBP1L1 GTF3C1 AP2B1 CLTC ITPRIP DYNC1H1 SLC27A3 CYB5R1 | 4.62e-06 | 1168 | 154 | 18 | 19946888 | |
| Pubmed | Gain of Additional BIRC3 Protein Functions through 3'-UTR-Mediated Protein Complex Formation. | TNPO1 DNHD1 EMC1 ACACA COPB1 DYNC2H1 DHX37 VPS13C CARS1 PSMD2 HEATR1 IDE URB2 NSUN2 POLR3A NUP205 GTF3C1 VPS33B CLTC DYNC1H1 | 5.32e-06 | 1425 | 154 | 20 | 30948266 |
| Pubmed | TNPO1 ABCF3 UNC13D HEATR1 PRAMEF18 TGFBR1 VPS33B CLMN UBP1 RASSF1 CLTC ZBTB40 CDK5RAP2 ITPRIP HERC1 DNA2 BICC1 | 6.89e-06 | 1084 | 154 | 17 | 11544199 | |
| Pubmed | Genetic link between renal birth defects and congenital heart disease. | 6.97e-06 | 28 | 154 | 4 | 27002738 | |
| Pubmed | Clint: a novel clathrin-binding ENTH-domain protein at the Golgi. | 7.01e-06 | 9 | 154 | 3 | 12429846 | |
| Pubmed | DNA-PKcs, but not TLR9, is required for activation of Akt by CpG-DNA. | 7.01e-06 | 9 | 154 | 3 | 15678105 | |
| Pubmed | 7.01e-06 | 9 | 154 | 3 | 21775285 | ||
| Pubmed | REC8 TNPO1 ACACA SZT2 INTS1 PSMD2 UNC13D NCAPH2 HEATR1 NSUN2 TMEM121 NUP205 TGFBR1 IGBP1 UBP1 CLTC ZBTB40 SNAPC2 EP300 | 7.05e-06 | 1327 | 154 | 19 | 32694731 | |
| Pubmed | A high-throughput approach for measuring temporal changes in the interactome. | TNPO1 ABCF3 ACACA COPB1 HGH1 CARS1 APEH PSMD2 UNC13D IDE NSUN2 NUP205 EHBP1L1 AP1B1 AP2B1 ARHGEF10 PANK4 HERC1 UROD DYNC1H1 | 7.23e-06 | 1455 | 154 | 20 | 22863883 |
| Pubmed | TNPO1 COPB1 PDK1 PSMD2 HOOK1 AP1B1 AP2B1 VPS33B CLTC PANK4 ASCC2 DYNC1H1 | 8.15e-06 | 560 | 154 | 12 | 35241646 | |
| Pubmed | 9.26e-06 | 30 | 154 | 4 | 24472646 | ||
| Pubmed | 9.99e-06 | 10 | 154 | 3 | 18765668 | ||
| Pubmed | 1.37e-05 | 33 | 154 | 4 | 26296893 | ||
| Pubmed | Multiplexed kinase interactome profiling quantifies cellular network activity and plasticity. | INTS1 SRPK1 CREBBP TGFBR1 PCGF6 GTF3C1 AP1B1 AP2B1 RALBP1 RASSF1 FDXR CDK5RAP2 AKT1 AKT2 EP300 | 1.38e-05 | 910 | 154 | 15 | 36736316 |
| Pubmed | FBXO22 promotes leukemogenesis by targeting BACH1 in MLL-rearranged acute myeloid leukemia. | ACACA HGH1 DHX37 MRM1 CCDC57 SYNGAP1 TRAFD1 GTF3C1 SEPTIN1 ASCC2 HERC1 | 1.46e-05 | 497 | 154 | 11 | 36774506 |
| Pubmed | 1.95e-05 | 2 | 154 | 2 | 27881875 | ||
| Pubmed | 1.95e-05 | 2 | 154 | 2 | 27878243 | ||
| Pubmed | 1.95e-05 | 2 | 154 | 2 | 27699769 | ||
| Pubmed | Molecular characterization of the histone acetyltransferase CREBBP/EP300 genes in myeloid neoplasia. | 1.95e-05 | 2 | 154 | 2 | 34845315 | |
| Pubmed | 1.95e-05 | 2 | 154 | 2 | 21658387 | ||
| Pubmed | 1.95e-05 | 2 | 154 | 2 | 9233772 | ||
| Pubmed | 1.95e-05 | 2 | 154 | 2 | 19729597 | ||
| Pubmed | Isoform-Specific Role of Akt in Oral Squamous Cell Carcinoma. | 1.95e-05 | 2 | 154 | 2 | 31252679 | |
| Pubmed | Akt1 is critical for acute inflammation and histamine-mediated vascular leakage. | 1.95e-05 | 2 | 154 | 2 | 19622728 | |
| Pubmed | Expression of AKT1 along with AKT2 in granulosa-lutein cells of hyperandrogenic PCOS patients. | 1.95e-05 | 2 | 154 | 2 | 28271235 | |
| Pubmed | 1.95e-05 | 2 | 154 | 2 | 17019809 | ||
| Pubmed | Increased Phospho-AKT in Blood Cells from LRRK2 G2019S Mutation Carriers. | 1.95e-05 | 2 | 154 | 2 | 35929078 | |
| Pubmed | 1.95e-05 | 2 | 154 | 2 | 39287984 | ||
| Pubmed | 1.95e-05 | 2 | 154 | 2 | 33377281 | ||
| Pubmed | Akt2 mRNA is highly expressed in embryonic brown fat and the AKT2 kinase is activated by insulin. | 1.95e-05 | 2 | 154 | 2 | 9620559 | |
| Pubmed | 1.95e-05 | 2 | 154 | 2 | 11861503 | ||
| Pubmed | 1.95e-05 | 2 | 154 | 2 | 20717166 | ||
| Pubmed | 1.95e-05 | 2 | 154 | 2 | 12808085 | ||
| Pubmed | 1.95e-05 | 2 | 154 | 2 | 15010337 | ||
| Pubmed | RLIP76 regulates PI3K/Akt signaling and chemo-radiotherapy resistance in pancreatic cancer. | 1.95e-05 | 2 | 154 | 2 | 22509328 | |
| Pubmed | 1.95e-05 | 2 | 154 | 2 | 36229454 | ||
| Pubmed | Akt2 regulates cardiac metabolism and cardiomyocyte survival. | 1.95e-05 | 2 | 154 | 2 | 16950770 | |
| Pubmed | 1.95e-05 | 2 | 154 | 2 | 25893291 | ||
| Pubmed | 1.95e-05 | 2 | 154 | 2 | 20332370 | ||
| Pubmed | 1.95e-05 | 2 | 154 | 2 | 11559821 | ||
| Pubmed | 1.95e-05 | 2 | 154 | 2 | 3037531 | ||
| Pubmed | 1.95e-05 | 2 | 154 | 2 | 32078465 | ||
| Pubmed | 1.95e-05 | 2 | 154 | 2 | 32576962 | ||
| Pubmed | 1.95e-05 | 2 | 154 | 2 | 19822209 | ||
| Pubmed | 1.95e-05 | 2 | 154 | 2 | 23076793 | ||
| Pubmed | Function of Akt/PKB signaling to cell motility, invasion and the tumor stroma in cancer. | 1.95e-05 | 2 | 154 | 2 | 19110052 | |
| Pubmed | 1.95e-05 | 2 | 154 | 2 | 23919516 | ||
| Pubmed | 1.95e-05 | 2 | 154 | 2 | 17804734 | ||
| Pubmed | 1.95e-05 | 2 | 154 | 2 | 24522976 | ||
| Pubmed | Targeting Ras-Driven Cancer Cell Survival and Invasion through Selective Inhibition of DOCK1. | 1.95e-05 | 2 | 154 | 2 | 28467910 | |
| Pubmed | 1.95e-05 | 2 | 154 | 2 | 27408773 | ||
| Pubmed | 1.95e-05 | 2 | 154 | 2 | 17141631 | ||
| Pubmed | CBP is required for environmental enrichment-induced neurogenesis and cognitive enhancement. | 1.95e-05 | 2 | 154 | 2 | 21847097 | |
| Pubmed | PI3K/AKT Signaling in Breast Cancer Molecular Subtyping and Lymph Node Involvement. | 1.95e-05 | 2 | 154 | 2 | 31781306 | |
| Pubmed | Role of Akt/protein kinase B in the activity of transcriptional coactivator p300. | 1.95e-05 | 2 | 154 | 2 | 15224190 | |
| Pubmed | Genetic analysis of the cytoplasmic dynein subunit families. | 1.95e-05 | 2 | 154 | 2 | 16440056 | |
| Pubmed | Beta-HPV 5 and 8 E6 promote p300 degradation by blocking AKT/p300 association. | 1.95e-05 | 2 | 154 | 2 | 21901101 | |
| Pubmed | Kleisins: a superfamily of bacterial and eukaryotic SMC protein partners. | 1.95e-05 | 2 | 154 | 2 | 12667442 | |
| Pubmed | p300 or CBP is required for insulin-stimulated glucose uptake in skeletal muscle and adipocytes. | 1.95e-05 | 2 | 154 | 2 | 34813504 | |
| Pubmed | 1.95e-05 | 2 | 154 | 2 | 30692211 | ||
| Pubmed | Distinct actions of akt1 on skeletal architecture and function. | 1.95e-05 | 2 | 154 | 2 | 24663486 | |
| Pubmed | 1.95e-05 | 2 | 154 | 2 | 19491266 | ||
| Pubmed | 1.95e-05 | 2 | 154 | 2 | 20301699 | ||
| Pubmed | 1.95e-05 | 2 | 154 | 2 | 15117818 | ||
| Pubmed | 1.95e-05 | 2 | 154 | 2 | 24639469 | ||
| Pubmed | 1.95e-05 | 2 | 154 | 2 | 37816914 | ||
| Pubmed | Akt1 and Akt2 are required for alphabeta thymocyte survival and differentiation. | 1.95e-05 | 2 | 154 | 2 | 17609365 | |
| Pubmed | 1.95e-05 | 2 | 154 | 2 | 17825284 | ||
| Interaction | ITGB3 interactions | 4.97e-06 | 170 | 149 | 9 | int:ITGB3 | |
| Interaction | TOP3B interactions | STK36 CRYBG2 ACACA GTPBP6 SZT2 TMEM8B INTS1 APEH TWNK TOR4A BTAF1 SMG5 ITGA5 ABCA7 EHBP1L1 CELSR2 NFATC1 LRRC31 A4GALT AKT1 AKT2 WDFY3 HERC1 KLHL14 DNA2 EP300 DYNC1H1 | 9.41e-06 | 1470 | 149 | 27 | int:TOP3B |
| Interaction | C1orf87 interactions | 1.56e-05 | 21 | 149 | 4 | int:C1orf87 | |
| Interaction | EEF1AKMT3 interactions | ABCF3 VPS13C WDR81 IGBP1 EHBP1L1 GTF3C1 HOOK1 ARHGEF10 SELENOO ASCC2 AKT1 HERC1 | 1.74e-05 | 364 | 149 | 12 | int:EEF1AKMT3 |
| Interaction | RUNX1 interactions | UBE2L6 GTPBP6 MYOD1 APEH CREBBP NFATC1 UBP1 CLTC CERCAM UROD EP300 | 3.01e-05 | 324 | 149 | 11 | int:RUNX1 |
| Interaction | EP300 interactions | TNPO1 EMC1 ABCF3 ACACA COPB1 HGH1 MYOD1 PSMD2 SRPK1 BTAF1 CREBBP TGFBR1 IGBP1 UTS2 GTF3C1 AP1B1 AP2B1 NFATC1 CLTC PANK4 AKT1 HERC1 DNA2 EP300 SON | 3.43e-05 | 1401 | 149 | 25 | int:EP300 |
| Interaction | SIRT7 interactions | TNPO1 ACACA COPB1 DHX37 INTS1 PSMD2 SRPK1 HEATR1 URB2 NSUN2 NUP205 GTF3C1 AP1B1 AP2B1 CLTC DYNC1H1 SON | 3.71e-05 | 744 | 149 | 17 | int:SIRT7 |
| Interaction | BAG5 interactions | REC8 UBE2L6 COPB1 VPS13C LRRK2 PSMD2 NSUN2 CREBBP ARHGEF10 CLTC CERCAM | 4.79e-05 | 341 | 149 | 11 | int:BAG5 |
| Interaction | FOXB1 interactions | 6.59e-05 | 135 | 149 | 7 | int:FOXB1 | |
| Interaction | CLEC16A interactions | TNPO1 EMC1 ACACA COPB1 SZT2 DYNC2H1 NCAPH2 HEATR1 IGBP1 TRAFD1 HOOK1 NFATC1 PANK4 DNA2 SON | 6.78e-05 | 629 | 149 | 15 | int:CLEC16A |
| Interaction | DUSP16 interactions | 6.92e-05 | 237 | 149 | 9 | int:DUSP16 | |
| Cytoband | 10q22-q23 | 1.13e-04 | 5 | 155 | 2 | 10q22-q23 | |
| Coexpression | COLDREN_GEFITINIB_RESISTANCE_UP | 4.26e-08 | 86 | 154 | 8 | M18134 | |
| Coexpression | GSE27241_WT_VS_RORGT_KO_TH17_POLARIZED_CD4_TCELL_TREATED_WITH_DIGOXIN_UP | CEP104 VPS13C CREBBP NUP205 GTF3C1 CELSR2 ZBTB40 HERC1 EP300 | 1.25e-06 | 180 | 154 | 9 | M8239 |
| ToppCell | LPS-IL1RA-Hematopoietic_Meg-Ery-Mes-Epi-like|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.33e-06 | 157 | 155 | 7 | bd45590da540a557dc8096980a45220fccb99505 | |
| ToppCell | LPS-IL1RA-Hematopoietic_Meg-Ery-Mes-Epi-like-Erythroid|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.33e-06 | 157 | 155 | 7 | 00c9a58b033b8b95b0d838f233dd077b62d8b02a | |
| ToppCell | 343B-Lymphocytic-ILC-ILC-1|343B / Donor, Lineage, Cell class and subclass (all cells) | 4.39e-06 | 188 | 155 | 7 | 8f6b45ad82bde65e044d17f0edbc3db90d457915 | |
| ToppCell | BAL-Control-Lymphocyte-B-B_cell|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 4.71e-06 | 190 | 155 | 7 | da7341a8a423e5fe4d8e733d8e50c10a3318ac1c | |
| ToppCell | wk_08-11-Epithelial-Proximal_epithelial-intermediate_neuroendocrine|wk_08-11 / Celltypes from embryonic and fetal-stage human lung | 4.71e-06 | 190 | 155 | 7 | 5f1863bce9400b7c932f0e4d0e012ec4e8d7e555 | |
| ToppCell | BAL-Control-Lymphocyte-B-B_cell-B_cell|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 4.71e-06 | 190 | 155 | 7 | 42312f7d79fe889397d32910b625793e2535cc26 | |
| ToppCell | BAL-Control-Lymphocyte-B-B_cell-B_cell-B_activate-7|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 4.71e-06 | 190 | 155 | 7 | 682418a7a2096743112eae3790d40e7e600612c0 | |
| ToppCell | TCGA-Prostate-Primary_Tumor-Prostate_Adenocarcinoma-Acinar_Adenocarcinoma-6|TCGA-Prostate / Sample_Type by Project: Shred V9 | 5.22e-06 | 193 | 155 | 7 | abd71b2cf667ef2b1c4d88acd0c1dd19a12ff659 | |
| ToppCell | droplet-Pancreas-PANCREAS-30m-Epithelial-pancreatic_B_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.58e-06 | 195 | 155 | 7 | 3e519cffa6144a62b06124642a14c9ff39b76554 | |
| ToppCell | droplet-Pancreas-PANCREAS-30m-Epithelial-pancreatic_B_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.58e-06 | 195 | 155 | 7 | 7796ea9247f4c63762f0de8490fed08b9717fa23 | |
| Drug | Be-H | 4.46e-07 | 24 | 150 | 5 | CID000444973 | |
| Disease | microcephaly (implicated_via_orthology) | 1.96e-05 | 32 | 148 | 4 | DOID:10907 (implicated_via_orthology) | |
| Disease | RUBINSTEIN-TAYBI SYNDROME 1 | 2.50e-05 | 2 | 148 | 2 | 180849 | |
| Disease | Rubinstein-Taybi syndrome due to CREBBP mutations | 2.50e-05 | 2 | 148 | 2 | cv:C4551859 | |
| Disease | Menke-Hennekam syndrome | 2.50e-05 | 2 | 148 | 2 | cv:C5681632 | |
| Disease | Rubinstein-Taybi syndrome (implicated_via_orthology) | 2.50e-05 | 2 | 148 | 2 | DOID:1933 (implicated_via_orthology) | |
| Disease | Rubinstein-Taybi syndrome | 2.50e-05 | 2 | 148 | 2 | cv:C0035934 | |
| Disease | RUBINSTEIN-TAYBI SYNDROME 1 | 2.50e-05 | 2 | 148 | 2 | C4551859 | |
| Disease | Rubinstein-Taybi syndrome (is_implicated_in) | 2.50e-05 | 2 | 148 | 2 | DOID:1933 (is_implicated_in) | |
| Disease | Rubinstein-Taybi Syndrome | 2.50e-05 | 2 | 148 | 2 | C0035934 | |
| Disease | alcohol use disorder (implicated_via_orthology) | 6.02e-05 | 195 | 148 | 7 | DOID:1574 (implicated_via_orthology) | |
| Disease | autism spectrum disorder (implicated_via_orthology) | 1.22e-04 | 152 | 148 | 6 | DOID:0060041 (implicated_via_orthology) | |
| Disease | obsolete_red blood cell distribution width | TNPO1 TMPRSS6 APEH PBX4 UNC13D NCAPH2 SMG5 ABCA7 EHBP1L1 HOOK1 AP2B1 VPS33B RP1L1 A4GALT ZBTB40 HERC1 STKLD1 EP300 | 1.48e-04 | 1347 | 148 | 18 | EFO_0005192 |
| Disease | hemojuvelin measurement | 2.47e-04 | 5 | 148 | 2 | EFO_0008148 | |
| Disease | erythrocyte measurement | 3.30e-04 | 257 | 148 | 7 | EFO_0005047 | |
| Disease | Inflammatory Myofibroblastic Tumor | 3.70e-04 | 6 | 148 | 2 | C0334121 | |
| Disease | mean corpuscular hemoglobin concentration | TNPO1 INTU TMPRSS6 PSMD2 SRPK1 SMG5 TSHR URB2 INTS8 ABCA7 EHBP1L1 HOOK1 RP1L1 A4GALT ASCC2 | 4.59e-04 | 1105 | 148 | 15 | EFO_0004528 |
| Disease | asphyxiating thoracic dystrophy (is_implicated_in) | 5.16e-04 | 7 | 148 | 2 | DOID:0050592 (is_implicated_in) | |
| Disease | cardiomyopathy (is_marker_for) | 5.16e-04 | 7 | 148 | 2 | DOID:0050700 (is_marker_for) | |
| Disease | HbA1c measurement | CEP104 CCDC184 TMPRSS6 SMG5 SBK1 HOOK1 CYP2R1 A4GALT ASCC2 QPCT STKLD1 | 6.25e-04 | 675 | 148 | 11 | EFO_0004541 |
| Disease | repulsive guidance molecule A measurement | 8.79e-04 | 9 | 148 | 2 | EFO_0008273 | |
| Disease | lactosyl-N-nervonoyl-sphingosine (d18:1/24:1) measurement | 8.79e-04 | 9 | 148 | 2 | EFO_0800517 | |
| Disease | Neoplasm of uncertain or unknown behavior of breast | 1.15e-03 | 41 | 148 | 3 | C0496956 | |
| Disease | Breast adenocarcinoma | 1.15e-03 | 41 | 148 | 3 | C0858252 | |
| Disease | mitochondrial DNA measurement | 1.38e-03 | 328 | 148 | 7 | EFO_0006312 | |
| Disease | waist-hip ratio, body mass index | 1.60e-03 | 12 | 148 | 2 | EFO_0004340, EFO_0004343 | |
| Disease | bilirubin measurement | 1.81e-03 | 442 | 148 | 8 | EFO_0004570 | |
| Disease | Benign tumor of pancreas | 1.88e-03 | 13 | 148 | 2 | C0347284 | |
| Disease | CD209 antigen measurement | 2.19e-03 | 14 | 148 | 2 | EFO_0008077 | |
| Disease | mean reticulocyte volume | TNPO1 INTU SRPK1 NCAPH2 URB2 ABCA7 NUP205 GTF3C1 HOOK1 AP2B1 ZBTB40 | 2.39e-03 | 799 | 148 | 11 | EFO_0010701 |
| Disease | IGFBP-3 measurement | 2.54e-03 | 54 | 148 | 3 | EFO_0004626 | |
| Disease | Small cell carcinoma of lung | 2.54e-03 | 54 | 148 | 3 | C0149925 | |
| Disease | Diffuse Large B-Cell Lymphoma | 2.68e-03 | 55 | 148 | 3 | C0079744 | |
| Disease | T-Cell Lymphoma | 2.86e-03 | 16 | 148 | 2 | C0079772 | |
| Disease | autosomal recessive polycystic kidney disease (implicated_via_orthology) | 2.86e-03 | 16 | 148 | 2 | DOID:0110861 (implicated_via_orthology) | |
| Disease | prostate cancer (is_implicated_in) | 2.91e-03 | 117 | 148 | 4 | DOID:10283 (is_implicated_in) | |
| Disease | Squamous cell carcinoma | 3.58e-03 | 124 | 148 | 4 | C0007137 | |
| Disease | very low density lipoprotein cholesterol measurement, esterified cholesterol measurement | 3.63e-03 | 18 | 148 | 2 | EFO_0008317, EFO_0008589 | |
| Disease | uric acid measurement | 3.76e-03 | 610 | 148 | 9 | EFO_0004761 | |
| Disease | Pancreatic carcinoma | 4.04e-03 | 19 | 148 | 2 | C0235974 | |
| Disease | hydrocephalus (implicated_via_orthology) | 4.04e-03 | 19 | 148 | 2 | DOID:10908 (implicated_via_orthology) | |
| Disease | prostate adenocarcinoma (is_implicated_in) | 4.47e-03 | 20 | 148 | 2 | DOID:2526 (is_implicated_in) | |
| Disease | sclerosing cholangitis | 4.49e-03 | 66 | 148 | 3 | EFO_0004268 | |
| Disease | calcium measurement | 4.54e-03 | 628 | 148 | 9 | EFO_0004838 | |
| Disease | Microcephaly | 4.68e-03 | 67 | 148 | 3 | C0025958 | |
| Disease | kidney disease (biomarker_via_orthology) | 4.93e-03 | 21 | 148 | 2 | DOID:557 (biomarker_via_orthology) | |
| Disease | Arthrogryposis | 4.93e-03 | 21 | 148 | 2 | C0003886 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| MRELVQPLLALLPDT | 576 | Q14146 | |
| ILMEEIRFPRTLGPE | 361 | P31749 | |
| LILMEEIRFPRTLSP | 361 | P31751 | |
| PEELRQALMPTLEAL | 1051 | Q09472 | |
| PDRLPLQMALTELET | 586 | O15013 | |
| RMPIPELDLSELEGL | 16 | Q13015 | |
| EDPNPLIRALAVRTM | 96 | P63010 | |
| MLPLDLRELFRDTPL | 141 | Q9NPC4 | |
| RLSLPMDIRLPQEFL | 96 | Q07002 | |
| LREMIQLPGARPILD | 241 | P22570 | |
| RLTPSDMPLLELKDI | 231 | Q9H1I8 | |
| EPARELMAVLLTPRF | 6 | Q8N2C3 | |
| PDLLLQMLKLLDPER | 141 | A6NHR8 | |
| PDLLLLDEPTNMLDV | 346 | Q9NUQ8 | |
| KPEELRQALMPTLEA | 1086 | Q92793 | |
| RPNRLPLLEFMITDL | 1716 | Q8IYW2 | |
| MKTLRDPSLPLLELQ | 886 | Q13085 | |
| EDPNPLIRALAVRTM | 96 | Q10567 | |
| LRLEDMSPERFLSPL | 1131 | Q9HCU4 | |
| QMDLISPLLLPVLLL | 2796 | Q96M86 | |
| LATLMPLPELRELDA | 4361 | Q96M86 | |
| ILMETLLYEQLLEPP | 11 | Q13323 | |
| ELLPLVLMFELPIAG | 201 | Q9H694 | |
| EPMPSLLDVRQLITL | 536 | Q86XH1 | |
| PPMLDVAELLTSLLR | 151 | Q8IZY2 | |
| LGPLAPEMIDSRVLE | 1186 | Q96SN8 | |
| TLELPLIPILAVMES | 426 | Q7Z5Q5 | |
| LRDLPENLLTKELMP | 271 | Q15311 | |
| IRIDMETELPSLLLP | 106 | O95072 | |
| PEAITILEAEPIRML | 191 | O95072 | |
| MPLVLPPELELLSLE | 466 | O95072 | |
| MSGEPELIELRELAP | 1 | Q9NS23 | |
| MDLLVLLDLIGAPNP | 241 | Q16769 | |
| LEMRLPDIPLRQVIA | 646 | Q75QN2 | |
| EAMGLPEAVLRAEPL | 486 | Q8IWB1 | |
| PPISLRRDLEHLMLL | 431 | Q92621 | |
| MKEISLLPDNLLRTP | 91 | Q15118 | |
| FMDALREPLPATLRI | 66 | Q08J23 | |
| ARLREAGLAPVPMII | 246 | P06132 | |
| LSRELPLGPADAMEL | 661 | Q8N201 | |
| RGLQLPAPLLDSMVE | 401 | O43824 | |
| MPAERRLPLSFVLDV | 101 | P0C870 | |
| REEDLQGLPLVEMPR | 171 | Q8TBE3 | |
| DDMVLQLLPALSTLP | 216 | Q8NAA5 | |
| PLRERMELLHSLLPQ | 856 | Q15751 | |
| DLNEMILLLPLCRPE | 101 | Q16772 | |
| MAAEDELQLPRLPEL | 1 | P78318 | |
| MEAPAERALPRLQAL | 1 | A6NF83 | |
| MELLSPPLRDVDLTA | 1 | P15172 | |
| LPLTLVPGERFRELM | 296 | Q6N069 | |
| ELLEPLMPAIRACLE | 131 | P53618 | |
| ILELLTPLQAELMRI | 426 | Q5VWM3 | |
| MVALLPFLPDLEELD | 106 | Q6UY01 | |
| VLEIPLLPENSMRAV | 516 | O95644 | |
| SRLLEPADMVLLSVP | 1111 | Q8N3D4 | |
| APDLILADLPRNIML | 1856 | Q5S007 | |
| LLDLERTLMLPLTEG | 261 | Q7L4E1 | |
| MDAEGLALLLPPVTL | 1 | Q15274 | |
| RKETLQALDMPVLPV | 41 | Q96RR1 | |
| LLELMQRIELPLSLP | 566 | Q8TE96 | |
| EMDRLERPLVDLPLL | 411 | Q9NVE7 | |
| PAEEVPLPRLRNMIE | 391 | Q9ULD6 | |
| PSMELGRLEIPAELA | 421 | Q96JP2 | |
| LRMLEPEPLAGLDQL | 441 | Q6PEZ8 | |
| DDLLVGAPLLMDRTP | 341 | P08648 | |
| PPDAQLLRLDNMLLA | 76 | Q9BYU1 | |
| LRMPPDVIRDILEGV | 3006 | Q8NCM8 | |
| SLLDAELMRRPFDLP | 291 | O60308 | |
| ELMRRPFDLPLQPLA | 296 | O60308 | |
| LNFEEMRALLDSLPP | 216 | Q9P2G3 | |
| GPILEMTLIPETELR | 1086 | Q14185 | |
| PILEMTLIPEAELRK | 1091 | Q92608 | |
| ATLIRLMPLEAGIPD | 1211 | O14981 | |
| ELVPDLKPRLGMTLQ | 476 | Q6VVX0 | |
| IFLDTLRSMEPPEIL | 766 | Q8N1P7 | |
| MLPLGSEPALNELLL | 1 | Q2TAC2 | |
| LLERVLMKDIATPIP | 781 | Q86UW7 | |
| LRQPDPVALLMLLVD | 21 | Q8TDM0 | |
| PVLDRADMEKLVIPA | 41 | O00292 | |
| RLDPMALLELVRVLD | 241 | Q92839 | |
| PAEILELTRLLPLMF | 111 | Q8NEG0 | |
| VLADSVLMEQPPLRR | 1791 | Q14204 | |
| PDLIEMVLDKLRPEN | 461 | P14735 | |
| VLLPESIPFLAELME | 2101 | Q9H583 | |
| LREKEPGLMPQVLLV | 111 | Q8N8Q3 | |
| RPILQSLLLPVMDQD | 621 | Q8N766 | |
| DPKLNPASAEIMLLR | 621 | Q9UJC3 | |
| RLHFLVIMRDIPELP | 256 | Q49AJ0 | |
| VRLAAPLAVLPMEPL | 526 | Q8N9H9 | |
| QPLRRMLPVDEFLPI | 491 | Q5T4B2 | |
| LPPLVLNREARALGM | 791 | P51530 | |
| RSPEMQEERLKLPIL | 241 | Q8IY37 | |
| EPALRMFQRLLALEP | 286 | Q52WX2 | |
| LFDEMPLIPRTILEE | 796 | Q9NZJ4 | |
| EPLDMPDITLLQLEG | 176 | Q52MB2 | |
| LESVFRIPPELDMSL | 241 | Q9BYE7 | |
| RIPPELDMSLLLEFI | 246 | Q9BYE7 | |
| ETLLAADPGLPARLM | 96 | Q9BTY7 | |
| IIPLVLSPDRDEDLM | 76 | Q96G25 | |
| LDVFMLTLPLEVELP | 1616 | Q5T011 | |
| ELERASLLQILPEML | 46 | O95399 | |
| DMEALNVLPPDVLTR | 226 | P49589 | |
| RLVLPMDDSEPPLNL | 646 | Q92581 | |
| SQLLRQIEALDPPMR | 166 | O14545 | |
| DLPSSLLLPEDMALR | 721 | Q9UPR3 | |
| LLLPEDMALRNLPPL | 726 | Q9UPR3 | |
| LALARELDIMEPKVP | 331 | Q13200 | |
| QPRMLVTFDEELRPL | 826 | Q13200 | |
| PDIHIMAPLIRSILL | 551 | A6NCM1 | |
| AELLRMAEARDIPVL | 86 | Q6IN84 | |
| SLLPEELEDQMPRLV | 656 | Q8TE76 | |
| LFKRIPAEDVPLLLM | 226 | O14802 | |
| PEDRIIDGRDLMPLL | 416 | P08842 | |
| SLEELRLAFRPQMDP | 486 | Q9BVL4 | |
| EASASEMLPLLLPLL | 6 | O43699 | |
| PDAARMPAEIVVLLD | 166 | Q9BUA3 | |
| LPMLELIPEKRATAA | 631 | Q96SB4 | |
| MLQLIRAILKVPEDP | 191 | Q9UHQ9 | |
| ELPLDPAKLDMLVAL | 101 | O75783 | |
| ELPISLLTRLALMDP | 1031 | Q9NRP7 | |
| GLMLAITLLEERLLP | 521 | Q6ZMH5 | |
| MEAAVAAPRPRLLLL | 1 | P36897 | |
| PLLLMLGQEDRRVPF | 666 | P13798 | |
| PPADPRLREDMALLA | 231 | Q969K4 | |
| DALHIPRLLEPEDIM | 256 | Q96JQ2 | |
| PLLLNDLLMVLSPRL | 1416 | Q00610 | |
| EVLIIPLLPMALVAP | 141 | Q6IBW4 | |
| LPMLPLADTEKLIRE | 326 | Q8WYJ6 | |
| EELLPELLPEMLLSE | 51 | Q15170 | |
| ELLPEMLLSEERPPQ | 56 | Q15170 | |
| EPMVLREFLRLASPL | 936 | Q8IZQ1 | |
| LLMLDEDEIHPLLIR | 56 | Q96PV0 | |
| MVLEPPREALTGELL | 1586 | Q8IWN7 | |
| ESLEPDLPALRAMGL | 226 | Q5K4L6 | |
| RNLLPLMLQIDPSDR | 271 | Q8NE28 | |
| VPGLFLLLVALDRME | 121 | Q9BTD3 | |
| NIREPLRMDLADLLT | 116 | O14933 | |
| NRLPPELFEQLRMLL | 406 | Q8IV45 | |
| EPLTVLMDSLLPVLG | 466 | Q9C0B7 | |
| PEEMVLLPRQARLFA | 2996 | Q709C8 | |
| ERPAVFAMRLLPVLD | 66 | A6NDV4 | |
| LMDPVDGPILASLLV | 161 | Q2NKQ1 | |
| LDSDVLDRPLNIMIP | 171 | Q92973 | |
| PLLVLDDVELMPRPL | 261 | Q9NXH8 | |
| RPGDRLLDLDIPMSV | 141 | Q9NZI7 | |
| ESLGPLRENPFMLLE | 51 | Q4KMQ1 | |
| RRLDPIITEEMPLLE | 901 | Q9Y2L5 | |
| ARLRPAAAPLEELTM | 1686 | Q12789 | |
| ELLPLSELSPPMLIE | 636 | Q8IWV8 | |
| VPLEDVDLVLELAPM | 71 | Q6ZRP0 | |
| VRESVLPEDAILPLM | 781 | Q70J99 | |
| HIEDLVMLPTPVLRL | 311 | Q8TAS1 | |
| AVVLDLLMSLPEELP | 231 | Q13487 | |
| ADLVRPLLPKDMERL | 1731 | P18583 | |
| PSLLRAEALLESPEM | 216 | Q562E7 | |
| LMDILPRISHEVLLP | 1361 | Q562E7 | |
| LPLDVDLLSMELPEF | 146 | Q9H267 | |
| VLPDMLPDLPVSLVL | 121 | Q5W0B7 | |
| PLDLLMEEIRREPGA | 546 | Q9NUA8 | |
| LQIPEHRRLMLSPEV | 156 | Q8IU80 | |
| ILAVLLPPVMLLIDG | 206 | Q96IK0 | |
| MRPADLLQLVLLLDL | 1 | P16473 | |
| LSPDLAAPLLLDIMQ | 2036 | Q9P2D8 | |
| LELPLIMLSGLPDTV | 426 | Q8TDW0 | |
| MELLLPEERLPAAVA | 321 | Q8N9H8 |